Figure (Fragmin 01)
Fragmin Injection
Product Images NDC 0069-0195
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Fragmin (NDC 0069-0195). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Fragmin 02)
Logo (Fragmin 03)
The text appears to be a label or heading for a product called "Injectables". It is distributed by a company named "Plizer Labs" that is a division of "Pfizer Inc" located in "New York NY 10017".*
Principal Display Panel (2,500 IU Syringe Label)
This is a product description for Fragmin® - a dalteparin sodium injection for subcutaneous injection. The packaging comes in a single dose and is produced by Pfizer Labs, a division of Pfizer Inc. The label also contains the National Drug Code (NDC) 0069-0195-01 and prescribing information for healthcare professionals. The last line appears to be a numeric code that may not be relevant to the product description.*
Principal Display Panel (2,500 IU Syringe Blister Pack)
This is a medication for subcutaneous injection labeled as "Fragmln (dalteparin sodium) Injection". The dosage and usage instructions are available on the accompanying document. The medication is stored in a prefilled syringe. The packaging contains a warning that the rubber latex used may cause allergic reactions. The medication is distributed by Pfizer and is only available on prescription. The NDC (National Drug Code) for this medication is 0069-0195-01. It is stored at a temperature ranging from 20°C to 25°C (68°F to 77°F), and the package allows for a 0.2 mL excursion.*
Principal Display Panel (2,500 IU Syringe Carton)
Fragmin (dalteparin sodium) is a sterile subcutaneous injection that is distributed in the United States by Injectables Rx only, a Pfizer Labs division, in 10 single-dose prefilled syringes, each preassembled with a needle guard. Each prefilled syringe contains 0.2 mL of Fragmin, which can be adjusted for tonicity by adding sodium chloride, and contains 2,500 IU (anti-Xa), equivalent to 16 mg of dalteparin sodium. When required, the pH of Fragmin is adjusted with hydrochloric acid and/or sodium hydroxide. The drug should be stored at a controlled room temperature of 15°C to 30°C (59°F to 86°F) or at 20°C to 25°C (68°F to 77°F) with an excursion allowed. The prescribing information should be consulted for dosage and usage instructions. The needle shield may contain natural rubber latex, which can cause allergic reactions. Made in Sweden.*
Principal Display Panel (5,000 IU Syringe Label)
Principal Display Panel (5,000 IU Syringe Blister Pack)
Store 1 liter of dalteparin sodium injection at a temperature between 15°C to 30°C (59°F to 86°F) with a concentration of 25% (X%). The injection is administered through a single-dose pre-filled syringe which contains 0.2 L of the medication. The needle shield may contain natural rubber latex which can cause allergic reactions. Distributed by Pfizer Labs with NDC 0069-0196-01 and manufactured specifically for subcutaneous injection only. No further information is available.*
Principal Display Panel (5,000 IU Syringe Carton)
Fragmin is a dalteparin sodium injection medication provided in 10 single-dose prefilled syringes with needle guards, each containing 5,000 IU per 0.2 mL of the solution. It is intended for subcutaneous injection and is sterile. Hydrochloric acid and/or sodium hydroxide can be used to adjust the pH of the solution when necessary, and the sodium chloride content is also adjusted at a concentration of 9 mg/mL. Fragmin is equivalent to 3.2 mg of dalteparin sodium with anti-Xa activity. It should be stored at 20°C to 25°C with limited excursions allowed between 15°C and 30°C. The needle shield may contain natural rubber latex, which for those who have a latex allergy can cause an allergic reaction. For dosage and usage information, please refer to the accompanying prescription. The GTIN is 0030690196022, and the lot number or expiration date is not available.*
Principal Display Panel (7,500 IU Syringe Label)
Principal Display Panel (7,500 IU Syringe Blister Pack)
This text is a description of a medication labeled as dalteparin sodium. The medication is in the form of a single-dose prefilled syringe and is distributed by Pfizer Labs. The text contains information about storage at different temperatures, dosage, and warnings about allergic reactions related to rubber latex. It also displays the medication's NDC code and manufacturer's address.*
Principal Display Panel (7,500 IU Syringe Carton)
This is a description of a medical product, the NDC 0069-0206-02, which consists of 10 prefilled syringes of dalteparin sodium, marketed under the brand name Fragmin®. Each syringe contains 0.3 mL of the medication for subcutaneous injection, with a dosage of 7,500 IU (anti-Xa) per 0.3 mL. The syringes are sold preassembled with needle guards for safe disposal. Store the medicine at room temperature between 20°C to 25°C (68°F to 77°F), with an excursion permitted between 15°C to 30°C (59°F to 86°F). The product is sterile and may cause allergic reactions. The packaging warns that the needle shield may contain natural rubber latex that could trigger allergies. The product is distributed by Pfizer Inc., NY, NY.*
Principal Display Panel (10,000 IU Syringe Label)
Principal Display Panel (10,000 IU Syringe Blister Pack)
Principal Display Panel (10,000 IU Syringe Carton)
This is a prescription drug called Fragmin (dalteparin sodium) Injection. The package contains 10 single-dose syringes with preassembled needle guards. The drug has a strength of 10,000 IU per milliliter and is intended for subcutaneous injection. The pH of the medicine is adjusted with hydrochloric acid, and sodium chloride may be added to adjust tonicity. Fragmin is sterile and made in Sweden, and distributed by Pfizer Inc. It should be stored between 15°C to 30°C and comes with dosage and usage instructions. There is also a caution about natural rubber latex present in the needle shield. The LOT/EXP date and GTIN code are present.*
Principal Display Panel (12,500 IU Syringe Label)
This is a description of a medication called Fragmin (dalteparin sodium) Injection. It comes in a single-dose package of 0.5 mL, with a strength of 12,500 IU per dose, and is intended for subcutaneous injection only. It is manufactured by Pfizer Labs, a division of Pfizer Inc, located in NY, NY 10017. It is only available with a prescription. No other information is available from this text.*
Principal Display Panel (12,500 IU Syringe Blister Pack)
This is a description of a medication called Fragmin (dalteparin sodium) Injection distributed by Pfizer Labs. The medication should be stored between 18°C to 30°C (64°F to 86°F) and is for subcutaneous injection only. The dosage and usage instructions can be found with the medication. The packaging mentions that it contains a rubber latex material which may cause allergic reactions.*
Principal Display Panel (12,500 IU Syringe Carton)
This is a description of a medication called Fragmin in the form of 10 0.5 mL single-dose pre-filled syringes with pre-assembled needle guards. Each syringe contains 12,500 IU of dalteparin sodium, intended for subcutaneous injection. The medication is sterile and should be stored between 20°C to 25°C (68°F to 77°F) with an excursion permitted between 15°C to 30°C (59°F to 86°F). The needle shield may contain natural rubber latex which could cause allergic reactions. For dosage and usage instructions, see the accompanying package insert. The medication is distributed by Pfizer Labs, a division of Pfizer Inc in New York, NY 10017.*
Principal Display Panel (15,000 IU Syringe Label)
Fragmin is an injectable medication containing dalteparin sodium, which is used for subcutaneous injections. Each single dose contains 15,000 IU per 0.6 mL. This medication is manufactured by Pfizer Labs, a division of Pfizer Inc. Fragmin is available with NDC 0069-0223-01 and is only available through a prescription.*
Principal Display Panel (15,000 IU Syringe Blister Pack)
Principal Display Panel (15,000 IU Syringe Carton)
Fragmin (dalteparin sodium) Injection is a sterile solution for subcutaneous injection presented in 10x 0.6 mL single-dose prefilled syringes. Each syringe is preassembled with needle guards and contains 15,000 IU per 0.6 mL. The medicine should be stored between 15°C to 30°C (59°F to 86°F) and is distributed by Pfizer Labs. The needle shield may contain natural rubber latex which can cause allergic reactions.*
Principal Display Panel (18,000 IU Syringe Label)
This is a medication description for Fragmin® i, also known as dalteparin sodium. It comes in a pre-filled syringe containing 18,000 IU per 0.72 mL and is meant for subcutaneous injection, with single-dose only. The manufacturer is Pfizer Labs, a division of Pfizer Inc, and this medication is available by prescription only (Rx only).*
Principal Display Panel (18,000 IU Syringe Blister Pack)
Store this medication at a temperature between 20°C to 25°C (68°F to 77°F) with an excursion allowed of 15°C to 30°C (5S°F to 86°F) as per USP Controlled Room Temperature guidelines. The dosage and usage information can be found with the accompanying prescription. The natural rubber latex in the needle shield may cause allergic reactions. The medication is available in a single-dose prefilled syringe of 0.72mL and it contains 18,000 IU per 0.72mL of Fragmin (dalteparin sodium). This medication is for subcutaneous use. The NDC number is 0069-0228-01, and it is distributed by Pfizer Labs.*
Principal Display Panel (18,000 IU Syringe Carton)
This is a description of a medication product by Pfizer Labs called Fragmin (dalteparin sodium) Injection. The product is packaged in 10 single-dose prefilled syringes, preassembled with needle guards. Each syringe contains 0.72 mL and 18,000 IU of the medication for subcutaneous injection. The product is sterile and made in Sweden. The recommended storage temperatures for the product are 20-25°C and 15-30°C. The Needle Shield may contain natural rubber latex, which may cause allergic reactions. The text also includes some product and packaging identifiers such as the National Drug Code (NDC) and the Global Trade Item Number (GTIN).*
Principal Display Panel (95,000 IU Vial Label)
This text provides instructions for storing and using dalteparin sodium injection, a medication distributed by Pfizer Labs. It advises to store the medication at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F) for injectables. The medication comes in a 3.8 mL multiple-dose vial and contains benzyl alcohol as a preservative. The text also suggests referring to the accompanying prescribing information for further details.*
Principal Display Panel (95,000 IU Vial Carton)
This is a description of the drug Fragmin. It is available in a 3.8ml multiple-dose vial, containing dalteparin sodium at a concentration of 25,000 IU/ml. It is indicated for subcutaneous injection and stored between 20°C to 25°C. The drug is a registered trademark of Pfizer Health and contains benzyl alcohol as a preservative. The pH is adjusted using hydrochloric acid and/or sodium hydroxide. For proper dosage and usage instructions, refer to the prescribing information. The drug is distributed by Pfizer Labs and is only available by prescription.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
